Cardiometabolic Specialists play a crucial role in addressing the complex interplay between cardiovascular health and metabolic disorders such as diabetes, obesity, and hypertension. These experts focus on identifying and managing risk factors that contribute to heart disease and metabolic syndrome, which together significantly increase the likelihood of cardiovascular events. By integrating knowledge from cardiology, endocrinology, and nutrition, they develop personalized treatment plans that aim to improve heart function while optimizing metabolic health. Their approach often includes lifestyle modification, pharmacotherapy, and regular monitoring to reduce the burden of these intertwined conditions. With the rising global prevalence of obesity and diabetes, their expertise has become more vital than ever.
In clinical settings and scientific gatherings, cardiometabolic specialists emphasize the importance of early detection and comprehensive care. They advocate for multidisciplinary collaboration to enhance patient outcomes, combining cutting-edge research with practical interventions. Through continued education and research, these specialists stay abreast of emerging therapies and diagnostic tools that can better predict and prevent cardiometabolic complications. Their work not only improves individual patient prognosis but also contributes to public health strategies aimed at reducing the prevalence of heart disease linked to metabolic abnormalities worldwide. Collaboration between specialists and primary care providers ensures holistic management of patients’ health, making care more efficient and effective.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India